Effects of Variation of Sodium Dialysate in ICU
Recruiting
Phase 2
Interventional Study
Acute Kidney Injury
Renal Replacement Therapy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 158 (estimated)
- Sponsor
- University Hospital, Montpellier · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Intermittent hemodialysis/diafiltration is a current renal replacement therapy (RRT) institued for ICU patients with AKI. For a better clinical tolerance, iinternational guidelines advise to use cold dialysate, increase duration session, decrease blood and dialysate flows, and increase level of sodium dialysate concentration (≥ 145mmol/l). Indeed, the use of a Na concentration dialysate \> 145 mmo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* Age \> 18 years old
* Acute kidney injury requiring renal replacement therapy
* Dialysis type: on line sustained low efficiency dialy dialysis -filtration
* SOFA score \> 5
* Sodium serum level between 135 and 145mmol/l
Exclusion criteria:
* Chronic kidney disease stade IV o…
Contacts